Management of non-prosthetic hip joint infection shares similarities with the treatment of periprosthetic joint infection, although some differences should be taken into account. Septic arthritis (SA) of the hip joint is a rare but serious condition. Risk factors for hip SA include age over 80, diabetes, inflammatory joint diseases, recent joint surgery, skin infection, intravenous drug use, and hemodialysis. Hematogenous dissemination is the most common route of infection. Gram-positive organisms, particularly SAMS, are the primary causative agents in adult hip SA, with increasing concern over methicillin-resistant strains. The clinical presentation typically includes groin pain, limited range of motion, fever, and joint swelling. Diagnosis relies on synovial fluid analysis, including culture, white blood cell count, and inflammatory markers. Imaging studies aid in assessing joint damage and adjacent tissue involvement. Treatment of acute hip SA is an orthopedic emergency, necessitating immediate antibiotic therapy and surgical joint debridement. Empirical antibiotics, including coverage for methicillin-resistant Staphylococcus aureus, are recommended. In cases of chronic or late-diagnosed infection with significant joint damage, one- or two-stage total hip arthroplasty may be considered. Infection following hip preservation surgery and following osteosynthesis of a previous hip fracture fixation can lead to significant complications, although its incidence is relatively low. Certain risk factors such as preoperative joint injections, comorbidities such as diabetes and prolonged surgical times can increase the likelihood of infection. Diagnosis involves clinical assessment, bloodwork, and joint aspiration for culture analysis. Treatment approaches range from open debridement to arthroscopic interventions, with conversion to total hip arthroplasty considered in cases of chronic infection or implant failure.